What is osteoporosis?

C Christodoulou, C Cooper, C Christodoulou, C Cooper

Abstract

Osteoporosis is a very common disorder, which results in an increase in fracture risk. The annual cost attributable to hip, vertebral, and wrist fractures in England and Wales is pound 1.7 billion. Significant mortality and morbidity are associated with osteoporotic fractures. The method that is most widely used for the diagnosis of osteoporosis is dual energy x-ray absorptiometry. The aim of prevention and treatment of osteoporosis is to prevent the occurrence of future fractures. Lifestyle changes should be encouraged in high risk patients. Pharmacological treatments include the bisphosphonates, hormone replacement therapy, selective oestrogen receptor modulators, calcitonin, the 1-34 fragment of parathyroid hormone, calcium and vitamin D supplements, and calcitriol.

References

    1. Clin Lab Med. 2000 Sep;20(3):439-53
    1. J Intern Med. 1998 Oct;244(4):271-92
    1. J Rheumatol. 2000 Oct;27(10):2424-31
    1. J R Coll Physicians Lond. 2000 Nov-Dec;34(6):518-21
    1. N Engl J Med. 2001 May 10;344(19):1434-41
    1. CMAJ. 2002 May 28;166(11):1426-30
    1. Clin Endocrinol (Oxf). 2002 Jun;56(6):703-11
    1. Lancet. 2002 Jun 8;359(9322):2018-26
    1. Calcif Tissue Int. 1989 Mar;44(3):228-32
    1. Ann Intern Med. 1990 Mar 1;112(5):352-64
    1. J Clin Endocrinol Metab. 1991 Jun;72(6):1372-4
    1. Lancet. 1991 Aug 10;338(8763):355-8
    1. N Engl J Med. 1991 Oct 24;325(17):1189-95
    1. Arch Intern Med. 1991 Oct;151(10):2026-32
    1. Br J Radiol. 1991 Nov;64(767):1023-9
    1. N Engl J Med. 1992 Feb 6;326(6):357-62
    1. J Bone Miner Res. 1992 Sep;7(9):1005-10
    1. Osteoporos Int. 1992 Nov;2(6):298-302
    1. N Engl J Med. 1992 Dec 3;327(23):1637-42
    1. Ann Intern Med. 1992 Dec 15;117(12):1016-37
    1. Lancet. 1993 Jan 9;341(8837):72-5
    1. Br J Radiol. 1992 Dec;65(780):1124-9
    1. Am J Epidemiol. 1993 May 1;137(9):1001-5
    1. Baillieres Clin Rheumatol. 1993 Oct;7(3):459-77
    1. J Bone Miner Res. 1994 Jul;9(7):963-70
    1. N Engl J Med. 1995 Mar 23;332(12):767-73
    1. Osteoporos Int. 1994 Nov;4(6):368-81
    1. J Clin Endocrinol Metab. 1995 Apr;80(4):1052-8
    1. N Engl J Med. 1995 Jun 15;332(24):1589-93
    1. BMJ. 1995 Jun 10;310(6993):1507-10
    1. J Bone Miner Res. 1997 Sep;12(9):1321-9
    1. BMJ. 1997 Oct 4;315(7112):841-6
    1. N Engl J Med. 1997 Dec 4;337(23):1641-7
    1. J Bone Miner Res. 1997 Nov;12(11):1761-8
    1. Am J Med. 2000 Sep;109(4):267-76

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe